We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Device Checks for Cancer Cells During Surgery

By Biotechdaily staff writers
Posted on 21 May 2002
A device that conducts an on-the-spot check for cancer cells during surgery is being developed by scientists at the Irish National Microelectronics Research Center (NMRC) of University College (Cork, Ireland; www.nmrc.ie). More...


During surgery, a surgeon will be able to collect a few cells and insert them into a device that looks like a computer chip. If cancerous, the cells will absorb a special dye, and light from a tiny on-chip laser will cause them to fluoresce. Noncancerous cells will not fluoresce. Cells of interest can be separated for a more detailed analysis.

The device is based on microfluidics, which deals with the manipulation of liquids in nano- and pico-liter amounts, as small as one 50-millionth of a drop of water. The fluid under study is placed in tiny channels, 50-100 microns wide. It can then be moved in various directions by air pressure or electrical forces. Tiny integrated components, such as semiconductor lasers and microvalves, can be placed on the chip to perform various functions. The processes can all be controlled by computer.

"The cancer-cell detection chip is to be reusable and silicon-based,” says Dr. Peter O'Brien, leader of the microfluidics team at the NMRC. "At a later stage, a disposable chip based on polymer could be designed for use by a general practitioner.”





Related Links:
Irish National Microelectronics Research Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Pipette Calibration System
Artel PCS®
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.